Speaker illustration

Doctor Victoria Orshanskaya

Almazov National Medical Research Centre, Saint Petersburg (Russian Federation)

Member of:

Heart Failure Association

Histomolecular fibrotic profile and an extent of the atrial and ventricular electroanatomical substrate in patients with atrial fibrillation and heart failure

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Heart Failure in Atrial Fibrillation

Session: Atrial Fibrillation ePosters

Thumbnail

Personalized interventional strategy in patients with long-standing persistent atrial fibrillation and chronic heart failure

Event: EHRA 2019

Topic: Rhythm Control, Catheter Ablation

Session: Rapid Fire 1: atrial fibrillation ablation: alternatives to improve success

Thumbnail

Personalized ablation strategy in patients with long-standing persistent atrial fibrillation and chronic heart failure.

Event: ESC Congress 2018

Topic: Rhythm Control, Catheter Ablation

Session: Atrial fibrillation - Ablation

Thumbnail

Association between an extent of electroanatomical substrate, circulating pro-fibrotic biomarkers and myocardial tissue morphology in patients with atrial fibrillation and heart failure.

Event: EHRA 2018

Topic: Heart Failure in Atrial Fibrillation

Session: Atrial fibrillation - Clinical

Thumbnail

Relationship between an extent of electroanatomical substrate, serum pro-fibrotic biomarkers and histopathological data in patients with atrial fibrillation and heart failure.

Event: ESC CONGRESS 2017

Topic: Atrial fibrillation (AF)

Session: Stroke prevention

Thumbnail

Relationship of the extent of left atrial electroanatomical substrate and risk of thromboembolic events in patients with atrial fibrillation.

Event: ESC CONGRESS 2016

Topic: Atrial fibrillation (AF)

Session: Best Posters in risk assessment of thromboembolic events in atrial fibrillation

Thumbnail

ESC 365 is supported by

logo Novo Nordisk